Pharmas sued for alleged scheme to fix prices of antidepressant

Charles McConnell

04 April 2017

A healthcare benefits fund based in New York filed a putative class action against several pharmaceutical companies on Friday for allegedly conspiring to raise the prices of generic amitriptyline, a tricyclic antidepressant tablet.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Charles McConnell

View full biography

Author | Senior reporter, Global Competition Review

[email protected]

Tipline

BCP, phone home: The Tipline for 24 June 2022
Competition is all the rage and the Federal Trade Commission’s bureau of consumer protection wants in on the fun. It's not the right-to-repair antitrust lawsuit you might have been dreaming up, but the commission says Harley Davidson and Westinghouse impeded fair competition by restricting customers from using independent repair shops. Also in Tipline, major appellate attorneys form their own firm and the Department of Justice’s antitrust division brings another fraud case.
Child’s play: The Tipline for 23 June 2022
Legislative solstice: The Tipline for 22 June 2022